首页> 外文期刊>Histology and histopathology >p53, latent membrane protein 1, bcl-2, and prognosis in nasopharyngeal carcinoma: a meta-analysis
【24h】

p53, latent membrane protein 1, bcl-2, and prognosis in nasopharyngeal carcinoma: a meta-analysis

机译:P53,潜在膜蛋白1,Bcl-2,鼻咽癌的预后:Meta分析

获取原文
获取原文并翻译 | 示例
           

摘要

The controversy of (p53) in nasopharyngeal carcinoma persists, despite the fact that many studies have been conducted on its correlation with latent membrane protein 1 (LMP1), bcl-2, and prognosis. To better understand this postulated relationship, a meta-analysis was performed based on existing relevant studies. A total of 19 individual studies with a total of 1189 patients were included in the meta-analysis. Overall, the results revealed a significant association of p53-positive status with a poor 5-year survival of nasopharyngeal carcinoma (NPC) patients as the risk difference (RD) was -0.17 (95% CI, -0.31, -0.03; P=0.02, Pheterogeneity=0.01). The overall odds ratio (OR) for LMP1 in the p53 positive group vs. negative group revealed that a significantly elevated risk of positive LMP1 in the former was achieved (OR 5.52 95% CI, 2.66-11.46; P0.00001, Pheterogeneity=0.78). Similarly, a strong correlation between bcl-2 and p53 was found with an OR 6.85 (95% CI, 2.37-19.74; P=0.0004, Pheterogeneity=0.48). However, there did not appear to be any correlations with clinical parameters such as gender, tumor site, lymph node metastasis, pathological type and TNM stage. In conclusion, p53 expression is related to the survival of nasopharyngeal carcinoma. It can be considered as the auxiliary detection index in treatment and prognosis of nasopharyngeal carcinoma.
机译:尽管有许多研究已经与潜伏膜蛋白1(LMP1),BCL-2和预后的相关性进行了许多研究,但鼻咽癌患者的争论仍然存在。为了更好地理解这种假设关系,基于现有相关研究进行了META分析。在Meta分析中,共有19个具有1189名患者的19例患者。总体而言,结果表明,由于风险差(RD)为-0.17(95%CI,-0.31,-0.03; p = 0.02,pheterogeneity = 0.01)。 P53阳性组中LMP1的总体差值(或)达到阴性组,达到了前者中阳性LMP1的显着升高的风险(或5.52 95%CI,2.66-11.46; P <0.00001,pheterogeneity = 0.78 )。类似地,发现Bcl-2和P53之间的强相关,用A或6.85(95%Ci,2.37-19.74; p = 0.0004,pheterogeneity = 0.48)。然而,似乎没有与临床参数的任何相关性,例如性别,肿瘤部位,淋巴结转移,病理型和TNM阶段。总之,P53表达与鼻咽癌的存活有关。它可以被认为是鼻咽癌治疗和预后的辅助检测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号